Subclinical atherosclerosis in Behcet’s disease: A systematic review and meta-analysis
Tài liệu tham khảo
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD), 2014, The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria, J Eur Acad Dermatol Venereol, 28, 338, 10.1111/jdv.12107
Desbois, 2014, Cardiovascular involvement in Behcet’s disease, Rev Méd Inter, 35, 103, 10.1016/j.revmed.2013.12.002
Sarica-Kucukoglu, 2006, Vascular involvement in Behçet’s disease: a retrospective analysis of 2319 cases, Int J Dermatol, 45, 919, 10.1111/j.1365-4632.2006.02832.x
Bayraktar, 1997, Budd–Chiari syndrome: a common complication of Behcet’s disease, Am J Gastroenterol, 92, 858
Geri, 2012, Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature, Medicine, 91, 25, 10.1097/MD.0b013e3182428f49
Gullu, 1998, Silent myocardial ischemia in Behcet’s disease, J Rheumatol, 23, 323
Kural-Seyahi, 2003, The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated centre, Medicine, 82, 60, 10.1097/00005792-200301000-00006
Seyahi, 2008, Atherosclerosis in Behçet’s Syndrome, Semin Arthritis Rheum, 38, 1, 10.1016/j.semarthrit.2007.09.009
Nambi, 2012, Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study, Eur Heart J, 33, 183, 10.1093/eurheartj/ehr192
Inoue, 2008, Flow-mediated vasodilation as a diagnostic modality for vascular failure, Hypertens Res, 31, 2105, 10.1291/hypres.31.2105
Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, Ann Intern Med, 1514, 65
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute. Available from: 〈http://www.ohri.ca/programs/clinical_epidemiology / oxford.htm〉.
Higgins, 2003, Measuring inconsistency in meta-analyses, Br Med J, 327, 557, 10.1136/bmj.327.7414.557
Tang, 2000, Misleading funnel plot fordetection of bias in meta-analysis, Clin Epidemiol, 253, 477, 10.1016/S0895-4356(99)00204-8
Lau, 2006, The case of the misleading funnel plot, Br Med J, 333, 597, 10.1136/bmj.333.7568.597
Riley, 2011, Interpretation of random effects meta-analyses, Br Med J, 342, d549, 10.1136/bmj.d549
Bradburn, 2007, Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events, Stat Med, 26, 53, 10.1002/sim.2528
Chambers, 2001, Vascular endothelial function and oxidative stress mechanisms in patients with Behçet’s syndrome, J Am Coll Cardiol, 37, 517, 10.1016/S0735-1097(00)01137-2
Ozdemir, 2004, Vascular endothelial function and plasma homocysteine levels in Behcet’s disease, Am J Cardiol, 94, 522, 10.1016/j.amjcard.2004.04.073
Kayikçioğlu, 2006, Endothelial functions in Behçet’s disease, Rheumatol Int, 26, 304, 10.1007/s00296-005-0590-1
Protogerou, 2006, Pressure wave reflections, central blood pressure, and aortic stiffness in patients with Adamantiades-Behcet’s disease: a cross-sectional case–control study underlining the role of chronic corticosteroid treatment, Am J Hypertens, 19, 660, 10.1016/j.amjhyper.2005.06.028
Caliskan, 2007, Endothelial functions are more severely impaired during active disease period in patients with Behcet’s disease, Clin Rheumatol, 26, 1074, 10.1007/s10067-006-0449-1
Ulusoy, 2008, Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behçet’s disease, Rheumatol Int, 28, 617, 10.1007/s00296-007-0491-6
Acikgoz, 2011, Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease, Angiology, 62, 296, 10.1177/0003319710382417
Yüksekkaya, 2012, An Assessment of flow-mediated dilatation in Behçet’s disease, Turk J Rheumatol, 27, 152, 10.5606/tjr.2012.026
Ozuguz, 2014, Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behcet disease, Angiology, 65, 937, 10.1177/0003319713512413
Alan, 2004, Intima-media thickness and arterial distensibility in Behçet’s disease, Angiology, 55, 413, 10.1177/000331970405500408
Keser, 2005, Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet’s disease, Clin Exp Rheumatol, 23, S71
Oztürk, 2006, Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet’s disease, Rheumatol Int, 26, 867, 10.1007/s00296-005-0098-8
Rhee, 2007, Intima-media thickness and arterial stiffness of carotid artery in Korean patients with Behçet’s disease, J Korean Med Sci, 22, 387, 10.3346/jkms.2007.22.3.387
Oztürk, 2008, Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet’s disease, Clin Rheumatol, 27, 961, 10.1007/s10067-007-0825-5
Hong, 2008, Carotid artery intima-media thickness in Behcet’s disease patients without significant cardiovascular involvement, Korean J Intern Med, 23, 87, 10.3904/kjim.2008.23.2.87
Messedi, 2011, Intima-media thickness of carotid artery in patients with Behçet’s disease, Arch Med Res, 42, 398, 10.1016/j.arcmed.2011.08.006
Ozgen, 2010, Serum adiponectin and vaspin levels in rheumatoid arthritis, Arch Med Res, 41, 457, 10.1016/j.arcmed.2010.08.012
Hassan, 2012, Subclinical atherosclerosis in Behçet’s disease, Turk J Rheumatol, 27, 109, 10.5606/tjr.2012.016
Caldas, 2013, Increased arterial stiffness assessed by pulse wave velocity in Behçet’s disease and its association with the lipid profile, J Eur Acad Dermatol Venereol, 27, 454, 10.1111/j.1468-3083.2012.04458.x
Oflaz, 2005, Impaired endothelium-dependent flow-mediated dilation in Behçet’s disease: more prominent endothelial dysfunction in patients with vascular involvement, Int J Clin Pract, 59, 777, 10.1111/j.1742-1241.2005.00477.x
Caliskan, 2008, Cardiovascular prognostic value of vascular involvement in Behcet’s disease, Int J Cardiol, 125, 428, 10.1016/j.ijcard.2007.01.057
Yurdakul, 2012, Evaluation of endothelial functions in patients with Behcet’s disease without overt vascular involvement, Turk Kardiyol Dern Ars, 40, 518, 10.5543/tkda.2012.43078
Can, 2012, Effect of vitamin D deficiency and replacement on endothelial functions in Behçet’s disease, Clin Exp Rheumatol, 30, S57
Peretz, 2007, Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization, BMC Cardiovasc Disord, 7, 11, 10.1186/1471-2261-7-11
Orem, 1999, Decreased nitric oxide production in patients with Behçet’s disease, Dermatology, 198, 33, 10.1159/000018061
Esmat, 2006, Lipoprotein (a) and nitrites in Behcet’s disease: relationship with disease activity and vascular complications, Eur J Dermatol, 16, 67
Skaug, 2013, Age and gender differences of endothelial function in 4739 healthy adults: the HUNT3 Fitness Study, Eur J Prev Cardiol, 20, 531, 10.1177/2047487312444234
Bekpinar, 2005, Evaluation of nitrosative and oxidative stress in Behçet disease, J Eur Acad Dermatol Venereol, 19, 167, 10.1111/j.1468-3083.2005.01075.x
Yeboah, 2007, Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study, Circulation, 115, 2390, 10.1161/CIRCULATIONAHA.106.678276
Teramukai, 2004, Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect, Jpn J Clin Oncol, 34, 717, 10.1093/jjco/hyh138
Ames, 2001, Thrombosis in Behcet’s disease: a retrospective survey from a single UK centre, Rheumatology, 40, 652, 10.1093/rheumatology/40.6.652
Desbois, 2012, Immunosuppressants reduce venous thrombosis relapse in Behçet’s disease, Arthritis Rheum, 64, 2753, 10.1002/art.34450
Saadoun, 2012, Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients, Medicine, 91, 18, 10.1097/MD.0b013e3182428126
Prandoni, 2006, Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis, J Thromb Haemost, 4, 1891, 10.1111/j.1538-7836.2006.02058.x
Sørensen, 2007, Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study, Lancet, 370, 1773, 10.1016/S0140-6736(07)61745-0